Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone-Reference-Cited by-同舟云学术

Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone

Published:2011-12 Issue:3 Volume:101 Page:486-489
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Faria Sergio,Pra Alan Dal,Cury Fabio,David Marc,Duclos Marie,Freeman Carolyn R.,Souhami Luis

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference34 articles.

1. Hormone therapy and radiotherapy for intermediate risk prostate cancer;Lee;Semin Radiat Oncol,2008

2. National Comprehensive Cancer Network Website. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Acessed in August, 2010.

3. Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer;Faria;Clin Oncol,2010

4. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10, 327 pretreatment daily ultrasound localizations;Poli;Int J Radiat Oncol Biol Phys,2007

5. Common Termonology Criteria for Adverse Events (CTCAE), National Institute. http://www.fda.gov/cder/cancer/toxicityframe.htm. Acessed in August, 2010.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early toxicity of hypofractionated radiotherapy for prostate cancer;Biomedical Papers;2016-09-20

2. Will intrafraction repair have negative consequences on extreme hypofractionation in prostate radiation therapy?;The British Journal of Radiology;2015-12

3. Hypofractionated radiation therapy for prostate cancer: The McGill University Health Center experience;Cancer/Radiothérapie;2015-10

4. Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?;Clinical Oncology;2014-04

5. Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon;Radiation Oncology Journal;2014